Biomarkers of Synaptic Damage in Multiple Sclerosis
Biomarkers of Synaptic Damage in Multiple Sclerosis
Recruiting · NCT03217396 · Registry updated 2022-10-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarkers of Synaptic Damage in Multiple Sclerosis | Alzheimer disease, CNS demyelinating autoimmune disease, Inflammation, Nerve Degeneration, Neuroinflammatory Diseases, Nutritional and Metabolic Diseases, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, demyelinating disease, immune system disorder, metabolic disease, motor neuron disorder, movement disorder, multiple sclerosis, nervous system disorder, neurodegenerative disease, neuromuscular disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, synucleinopathy, tauopathy | Recruiting | Not stated | 2022-10-28 | NCT03217396 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| IRCCS Multimedica | 10 |
| Neuromed IRCCS | 13 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| IRCCS Neuromed | Pozzilli | Italy | 3 |